This test is the critical partner to the IgG test, used to detect an active or recent autoimmune attack. It measures the "first-responder" (IgM) antibodies against Beta-2-Glycoprotein 1. A positive IgM result is a crucial, time-sensitive marker that strongly suggests a current or new-onset autoimmune process. It is essential for diagnosing Antiphospholipid Syndrome (APS) and understanding your current risk for clotting. This simple blood test provides the 'real-time' data your doctor needs to make an accurate, fast diagnosis.